BIONEXUS GENE LAB CORP (BGLC) Stock Price & Overview
NASDAQ:BGLC • US0906283066
Current stock price
The current stock price of BGLC is 2.24 USD. Today BGLC is up by 0.45%. In the past month the price increased by 10.34%. In the past year, price decreased by -36%.
BGLC Key Statistics
- Market Cap
- 5.286M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -1.28
- Dividend Yield
- N/A
BGLC Stock Performance
BGLC Stock Chart
BGLC Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to BGLC. When comparing the yearly performance of all stocks, BGLC is a bad performer in the overall market: 92.16% of all stocks are doing better.
BGLC Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to BGLC. BGLC has a great financial health rating, but its profitability evaluates not so good.
BGLC Earnings
BGLC Forecast & Estimates
BGLC Groups
Sector & Classification
BGLC Financial Highlights
Over the last trailing twelve months BGLC reported a non-GAAP Earnings per Share(EPS) of -1.28. The EPS decreased by -220.64% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -30.14% | ||
| ROE | -33.7% | ||
| Debt/Equity | 0 |
BGLC Ownership
BGLC Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| FAST | FASTENAL CO | 36.55 | 52.203B | ||
| GWW | WW GRAINGER INC | 24.41 | 50.873B | ||
| URI | UNITED RENTALS INC | 15.83 | 46.445B | ||
| FERG | FERGUSON ENTERPRISES INC | 17.6 | 43.422B | ||
| WSO | WATSCO INC | 28.81 | 14.949B | ||
| WSO.B | WATSCO INC -CL B | 27.97 | 14.907B | ||
| QXO | QXO INC | 49.97 | 14.299B | ||
| WCC | WESCO INTERNATIONAL INC | 16.07 | 12.462B | ||
| AIT | APPLIED INDUSTRIAL TECH INC | 21.79 | 9.536B | ||
| CNM | CORE & MAIN INC-CLASS A | 15.6 | 9.396B | ||
| AL | AIR LEASE CORP | 12.71 | 7.211B | ||
| GATX | GATX CORP | 16.51 | 5.982B | ||
| SITE | SITEONE LANDSCAPE SUPPLY INC | 29.52 | 5.771B |
Related stock screener links
View all stocks in the Trading Companies & Distributors Industry | View all stocks in the Industrials Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About BGLC
Company Profile
BioNexus Gene Lab Corp. operates as a holding company, which engages in the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries. The company is headquartered in Kuala Lumpur, Wilayah Persekutuan. The company went IPO on 2020-03-11. The Company, through its wholly owned subsidiary Chemrex Corporation Sdn. Bhd., focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its segments include Trading of industrial chemicals, Provision for genomic screening services, and Investment holding. The Provision for genomic screening services segment includes commercializing proprietary blood-based diagnostic test for early disease detection. Its subsidiary MRNA Scientific Sdn. Bhd owns algorithm software, technology, and know-how related to the detection of common diseases through blood analysis which it uses in its business.
Company Info
IPO: 2020-03-11
BIONEXUS GENE LAB CORP
10-2 Tower B, Vertical Business Suite, 8 Jalan Kerinchi
KUALA LUMPUR WILAYAH PERSEKUTUAN MY
Employees: 30
Phone: 13072416898
BIONEXUS GENE LAB CORP / BGLC FAQ
What does BGLC do?
BioNexus Gene Lab Corp. operates as a holding company, which engages in the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries. The company is headquartered in Kuala Lumpur, Wilayah Persekutuan. The company went IPO on 2020-03-11. The Company, through its wholly owned subsidiary Chemrex Corporation Sdn. Bhd., focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its segments include Trading of industrial chemicals, Provision for genomic screening services, and Investment holding. The Provision for genomic screening services segment includes commercializing proprietary blood-based diagnostic test for early disease detection. Its subsidiary MRNA Scientific Sdn. Bhd owns algorithm software, technology, and know-how related to the detection of common diseases through blood analysis which it uses in its business.
Can you provide the latest stock price for BIONEXUS GENE LAB CORP?
The current stock price of BGLC is 2.24 USD. The price increased by 0.45% in the last trading session.
Does BIONEXUS GENE LAB CORP pay dividends?
BGLC does not pay a dividend.
How is the ChartMill rating for BIONEXUS GENE LAB CORP?
BGLC has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the Price/Earnings (PE) ratio of BIONEXUS GENE LAB CORP (BGLC)?
BIONEXUS GENE LAB CORP (BGLC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.28).
What is the market capitalization of BGLC stock?
BIONEXUS GENE LAB CORP (BGLC) has a market capitalization of 5.29M USD. This makes BGLC a Nano Cap stock.